Fannin Innovation Studio is actively seeking Therapeutics interns and has an Open House coming up on May 26th
Fannin primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators in the Texas Medical Center and on a national stage. Fannin develops and de-risks these technologies via preclinical work and engineering up through early clinical trials. Additionally, Fannin builds the business model and use case, resulting in strategic partnerships or acquisitions.
Our internship program provides hands-on operational experience in early-stage life science development. Fannin offers two tracks in our internship program: Therapeutics and Medical Devices. Our interns work closely with established and potential portfolio companies, experientially learning about biomedical commercialization. Interns might be tasked with assisting with due diligence, working on market analysis, assisting with product development, or researching and understanding key regulatory requirements. All interns work closely with the core Fannin team to ensure a beneficial and useful experience.
We have had many interns and Fellows complete our program, and we look forward to receiving interest from more of your members!
Questions? Contact Serena Miggins or Stephanie Vega
https://fannininnovation.com/careers/
- AI in Drug Development: Faster, Cheaper, More Effective – Electropages
AI accelerates drug development, reducing costs and boosting clinical success rates. Discover how AI is reshaping the future of medicine. - Breast Cancer Breakthrough – The Medicine Maker
So promising is this discovery that the researchers believe a single dose could help reduce the risk of side effects and late effects, although … - There is no 'amyloid cabal' in Alzheimer's research – STAT News
The U.S. Food and Drug Administration, then drug regulators in Japan, China, Israel, UAE and Korea, and then the European Medicines Agency have all … - Scientific workflow for hypothesis testing in drug discovery: Part 3 of 3
This article highlights key tools and technologies in drug discovery, including AI, data analysis platforms, and network mapping. - Antibiotic resistance linked to lack of nutrients, not tough bacteria – Drug Target Review
Breaking new ground in antibiotic research. Study reveals nutrient starvation as the main cause of reduced effectiveness, not persisters.